Search Login Register

Chronic-Phase Myeloid Leukemia (Leukemia, Myeloid, Chronic Phase) Summary

Description: The initial phase of chronic myeloid leukemia consisting of an relatively indolent period lasting from 4 to 7 years. Patients range from asymptomatic to those exhibiting ANEMIA; SPLENOMEGALY; and increased cell turnover. There are 5% or fewer blast cells in the blood and bone marrow in this phase.

Also Known As: Leukemia, Myeloid, Chronic Phase; Leukemia, Myeloid, Chronic-Phase; Granulocytic Leukemia, Chronic, Stable Phase; Leukemia, Granulocytic, Chronic Phase; Leukemia, Myelogenous, Chronic Phase; Leukemia, Myeloid, Stable Phase; Myelogenous Leukemia, Chronic, Chronic Phase; Myeloid Leukemia, Chronic, Chronic Phase; Granulocytic Leukemia, Chronic, Stable-Phase; Leukemia, Granulocytic, Chronic-Phase; Leukemia, Myelogenous, Chronic-Phase; Leukemia, Myeloid, Stable-Phase; Myelogenous Leukemia, Chronic, Chronic-Phase; Myeloid Leukemia, Chronic, Chronic-Phase; Myeloid Leukemia, Chronic, Stable-Phase

Networked: 5 relevant articles (0 outcomes, 1 trials/studies) for this Disease

Key Drugs and Agents for Chronic-Phase Myeloid Leukemia

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. imatinib (Gleevec) : 1 study in 5 results : FDA 3
  2. Cytarabine (Cytosar-U) : 1 study in 1 result : FDA 13 Generic
  3. Interferon-alpha (Interferon Alfa) : 2 results : FDA 2

Diseases Related to Chronic-Phase Myeloid Leukemia

  1. Philadelphia Chromosome

Key Therapies for Chronic-Phase Myeloid Leukemia

Efficacy Chart >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.